Oncometabolites d- and l-2-Hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions
- 7 March 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 30 (4) , 1102-1110
Abstract
Cancer-associated mutations often lead to perturbed cellular energy metabolism and accumulation of potentially harmful oncometabolites. One example is the chiral molecule 2-hydroxyglutarate (2HG); its two stereoisomers (d- and l-2HG) have been found at abnormally high concentrations in tumors featuring anomalous metabolic pathways. 2HG has been demonstrated to competitively inhibit several α-ketoglutarate (αKG)- and non-heme iron-dependent dioxygenases, including some of the AlkB family DNA repair enzymes, such as ALKBH2 and ALKBH3. However, previous studies have only provided the IC50 values of d-2HG on the enzymes, and the results have not been correlated to physiologically relevant concentrations of 2HG and αKG in cancer cells. In this work, we performed detailed kinetic analyses of DNA repair reactions catalyzed by ALKBH2, ALKBH3, and the bacterial AlkB in the presence of d- and l-2HG in both double- and single-stranded DNA contexts. We determined the kinetic parameters of inhibition, including kcat, KM, and Ki. We also correlated the relative concentrations of 2HG and αKG previously measured in tumor cells with the inhibitory effect of 2HG on the AlkB family enzymes. Both d- and l-2HG significantly inhibited the human DNA repair enzymes ALKBH2 and ALKBH3 at pathologically relevant concentrations (73–88% for d-2HG and 31–58% for l-2HG inhibition). This work provides a new perspective that the elevation of the d- or l-2HG concentration in cancer cells may contribute to an increased mutation rate by inhibiting the DNA repair performed by the AlkB family enzymes and thus exacerbate the genesis and progression of tumors.Keywords
Funding Information
- National Institute of Environmental Health Sciences (P30 ES002109)
- National Cancer Institute (P01 CA26731, R01 CA080024)
- National Institute of General Medical Sciences (2 P20 GM103430)
- Rhode Island Foundation
This publication has 61 references indexed in Scilit:
- Adaptive Response Enzyme AlkB Preferentially Repairs 1-Methylguanine and 3-Methylthymine Adducts in Double-Stranded DNAChemical Research in Toxicology, 2016
- Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating AgentsCell Reports, 2015
- l-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal CancerCancer Discovery, 2014
- Removal of N-Alkyl Modifications from N2-Alkylguanine and N4-Alkylcytosine in DNA by the Adaptive Response Protein AlkBChemical Research in Toxicology, 2013
- DNA Repair by Reversal of DNA DamageCold Spring Harbor Perspectives in Biology, 2013
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Mechanistic insight into the recognition of single-stranded and double-stranded DNA substrates by ABH2 and ABH3Molecular BioSystems, 2010
- Kinetic studies of Escherichia coli AlkB using a new fluorescence-based assay for DNA demethylationNucleic Acids Research, 2007
- Alleviation of 1, N 6 -ethanoadenine genotoxicity by the Escherichia coli adaptive response protein AlkBProceedings of the National Academy of Sciences, 2007
- Repair of Methylation Damage in DNA and RNA by Mammalian AlkB HomologuesJournal of Biological Chemistry, 2005